About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) submitted the following response to a request from Representative Greg Walden and Senator Lamar Alexander for input on modernizing the 340B drug pricing program. PhRMA is pleased to provide input on how the 340B Drug Pricing Program (340B) can be strengthened to better support our nation’s most vulnerable patients. We look forward to continuing our conversations on meaningful improvements that can be made to ensure the 340B program is overseen and operated in a way that sustains the program for the long-term so that patients more directly benefit from the discounts provided by biopharmaceutical manufacturers.
PhRMA Response to Request for Input on Modernizing the 340B Drug Pricing Program Issued by Representative Greg Walden and Senator Lamar Alexander image
Comment
340B
PhRMA Response to Request for Input on Modernizing the 340B Drug Pricing Program Issued by Representative Greg Walden and Senator Lamar Alexander
PhRMA Response to Request for Input on Modernizing the 340B Drug Pricing Program Issued by Representative Greg Walden and Senator Lamar Alexander image